Article
For John Bingner Lyman, MD, time spent in his wood shop is just plane fun.
FDA accepts new drug application for low-dose atropine from Sydnexis
ROP: Treating and preventing blindness in preterm babies
AI and eye tracking: Technological companions to assess amblyopia in pediatric patients
Managing a changing landscape of IRD pediatric cases
Study highlights strong parental cooperation in preschool vision screening
Vyluma announces NMPA of China accepts drug application of NVK002 (low-dose atropine 0.01%) for myopia progression in children
